Our Company
Our Team
We're a dedicated and passionate team driven by the deeper purpose of our work.
Our organization leverages expert product design informed by extensive academic and clinical experience, and skilled software engineering with significant radiotherapy-specific domain expertise. We benefit from longstanding relationships with corporate and clinical collaborators, supported by a substantial regulatory infrastructure and a robust quality management system. Together, these strengths underpin our proven track record of commercial success in the field.
Corporate Leadership
Andy serves as Chief Executive Officer of Radialogica and has over twenty-five years of executive leadership and private equity investment experience in the healthcare industry. He previously served as President and Chief Executive Officer of CMS, Inc., the radiotherapy treatment planning company, where he led the successful strategic repositioning and operational restructuring of the business and subsequent sale to Elekta AB. Prior to joining CMS he served for twelve years as an executive of Brown Brothers Harriman in its private equity investment group, with primary responsibility for Brown Brothers' healthcare-oriented venture and growth capital investments. Andy is a Phi Beta Kappa and summa cum laude graduate of Bowdoin College and earned his MBA from the Wharton School of the University of Pennsylvania.
Scott serves as Chief Operating Officer of Radialogica with responsibility for research and product development and service delivery. He previously served as Chief of Clinical Development in the Department of Radiation Oncology at the Washington University School of Medicine and Siteman Cancer Center. Prior to joining the faculty at Washington University, he served as Senior Vice President of Clinical Design and Research at CMS, Inc., before which he was a Research Fellow at the Memorial Sloan-Kettering Cancer Center in New York City. Scott’s research interests focus on the application of Bayesian statistics and decision theory to problems in Oncology. He received his Ph.D. from the University of Tennessee and his MBA from the Olin School of Business at Washington University in St. Louis.
Clinical Leadership
Dr. Robinson is a Professor of Radiation Oncology and Cardiology at Washington University in St. Louis. He holds several leadership roles, including Associate Director of Clinical Programs, Medical Director of Radiation Oncology Clinical Research, Chief of the Cardiothoracic and Stereotactic Body Radiotherapy services, and Co-Director of the Center for Noninvasive Cardiac Radiotherapy. Dr. Robinson has established research interests developing and standardizing advanced radiotherapy technologies and novel drug combinations, promoting and codifying multi-disciplinary care and patient-centered decision making, and developing and testing new indications for radiotherapy. He is a Principal investigator for the international randomized PACIFIC-4 trial examining SBRT with or without immunotherapy for early stage lung cancer, a multi-center NIH R01 funded trial examining patient-centered decision making for early stage lung cancer, and an NIH U54 center grant exploring tumor microenvironment effects after radiotherapy. He is also a key developer of the pivotal randomized Varian sponsored RADIATE-VT trial comparing cardiac radioablation to repeat catheter ablation for patients with high risk refractory ventricular tachycardia.
Dr. Salma Jabbour is Professor, Vice Chair of Clinical Research and Faculty Development in Radiation Oncology, and Associate Director of Faculty Affairs and Development at the Rutgers Cancer Institute of New Jersey. She leads the Radiation Oncology Disease Specific Group. Dr. Jabbour's clinical practice and research focus on lung cancers and gastrointestinal malignancies and she is the Lead Thoracic and GI Radiation Oncologist. Dr. Jabbour's clinical research resulted in many influential publications in major journals. She has authored over 230 articles and numerous book chapters and monographs. She served previously as the Senior Editor for the International Journal of Radiation Oncology, Biology and Physics (IJROBP) and Deputy Editor of the IJROBP. She participates in multiple ASTRO committees and was selected as Fellow of ASTRO. She also participates in the Big Ten Cancer Research Consortium Steering Committee and is Chair of the Scientific Review Board at the Rutgers Cancer Institute as well as Leader of the Radiation Oncology Disease Specific Group which she founded.
Dr. Kruser is a radiation oncologist who practices in Madison, WI with a focus on central nervous system tumors as well as lung, head and neck, and genitourinary malignancies. He was previously an Assistant Professor and the Director of Stereotactic Radiation at Northwestern Memorial Hospital in Chicago, where his research focused on clinical trial development in benign and malignant brain tumors, brain metastases, and lung cancer. He has established expertise in radiation quality assurance, and in that vein currently serves as the radiation oncology chair of NRG Oncology BN011, a national randomized trial in glioblastoma, as well as radiation oncology co-chair of NRG Oncology BN003, a randomized examination of postoperative radiation in meningioma.